Skip Navigation

Advertise|Press|Contact|FAQ|About Us

Bookmark/Print/Share

Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Musculoskeletal | Rheumatology | Nephrology | Family Medicine
Disease Category: Gout (Hyperuricemia)
Location: United States, MI

Clinical Trial Details

Overview

Research Study Summary

Phase III Gout Study

Purpose

This long term study evaluates the safety and efficacy of an investigational treatment compared to allopurinol in people who have both gout and cardiovascular disease. Participants will receive compensation for their time and travel; $50 for each completed office visit and $15 for each completed telephone call throughout the study. There are up to 7 scheduled visits in the first year and every 6 months thereafter. The study is expected to last approximately 5 years. Study medication, examinations and bloodwork will be provided at no cost.

Patient Inclusion Criteria:

  • History of cardiovascular disease

Patient Exclusion Criteria:

  • History of Hep B, Hep C, or HIV.

To Learn more
Phase

3

Gender

Both Male and Female

Age

N/A

Overall Status

Recruiting

Duration

5 Years

Facility Type

N/A

Compensation

$50 to $750

Contact

Quest Research Institute
31000 Telegraph Ste. 230
Bingham Farms, MI 48025
Phone: 248-644-7770

View Map

Research Center Information: Quest Research Institute

CW ID: 169034

Date Last Changed: July 23, 2013


DISCLAIMER: CenterWatch does not conduct clinical research. CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies, contract research organizations, clinical research sites and other interested parties. This information is designed to help patients find clinical trials of interest and contact the research centers conducting the trials.